In the TA muscle, the late administration group showed a decreasing trend, although no statistically significant difference was observed (Fig. 5 b).
← all excerpts
Continuous adipose-derived stem cell therapy from the neonatal stage effectively reduces Duchenne muscular dystrophy symptoms in rats.
1
—
—